Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hospital Provider's Perspectives on MOUD Initiation and Continuation After Inpatient Discharge.
Shearer R, Englander H, Hagedorn H, Fawole A, Laes J, Titus H, Patten A, Oot E, Appleton N, Fitzpatrick A, Kibben R, Fernando J, McNeely J, Gustafson D, Krawczyk N, Weinstein Z, Baukol P, Ghitza U, Siegler T, Bart G, Bazzi A. Shearer R, et al. Among authors: fitzpatrick a. J Gen Intern Med. 2024 Nov 25. doi: 10.1007/s11606-024-09008-x. Online ahead of print. J Gen Intern Med. 2024. PMID: 39586949
Exploring the Relationship Between Radiation-Induced Moya Moya Syndrome and Radiation Dose for Pediatric Patients Treated with Proton Radiation Therapy: Moya Moya in Peds Patients After Proton RT.
Gill GS, Baliga S, Lewy J, Bajaj BV, Gallotto SL, Fitzpatrick A, Patteson B, Speroni S, Omsberg A, Caruso P, Rapalino O, Musolino P, Yock TI. Gill GS, et al. Among authors: fitzpatrick a. Int J Radiat Oncol Biol Phys. 2024 Nov 14:S0360-3016(24)03639-3. doi: 10.1016/j.ijrobp.2024.11.070. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39549759
Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial.
Gómez LF, Kinnee E, Kaufman JD, Young MT, Fitzpatrick AM, Phipatanakul W, Mauger DT, McClure LA, Bilal U, Holguin F, Clougherty JE. Gómez LF, et al. Among authors: fitzpatrick am. Respir Med. 2024 Nov-Dec;234:107853. doi: 10.1016/j.rmed.2024.107853. Epub 2024 Nov 5. Respir Med. 2024. PMID: 39510322 Free article. Clinical Trial.
A single risk assessment for the most common diseases of ageing, developed and validated on 10 cohort studies.
Huque MH, Kootar S, Kiely KM, Anderson CS, van Boxtel M, Brodaty H, Sachdev PS, Carlson M, Fitzpatrick AL, Whitmer RA, Kivipelto M, Jorm L, Köhler S, Lautenschlager NT, Lopez OL, Shaw JE, Matthews FE, Peters R, Anstey KJ. Huque MH, et al. Among authors: fitzpatrick al. BMC Med. 2024 Oct 31;22(1):501. doi: 10.1186/s12916-024-03711-6. BMC Med. 2024. PMID: 39482675 Free PMC article.
Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.
Chen X, Habib S, Alexandru M, Chauhan J, Evan T, Troka JM, Rahimi A, Esapa B, Tull TJ, Ng WZ, Fitzpatrick A, Wu Y, Geh JLC, Lloyd-Hughes H, Palhares LCGF, Adams R, Bax HJ, Whittaker S, Jacków-Malinowska J, Karagiannis SN. Chen X, et al. Among authors: fitzpatrick a. Cancers (Basel). 2024 Sep 25;16(19):3260. doi: 10.3390/cancers16193260. Cancers (Basel). 2024. PMID: 39409881 Free PMC article. Review.
844 results